Clinical Trials
6 trialsNCT03960437 2023-09-21
Parsabiv-MBD
Columbia University
Phase 2 Completed
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT03072186 2021-04-26
ICG2
Ohio State University
Phase NA Completed
NCT03050203 2019-01-28
kit
Istituto Ortopedico Rizzoli
Phase NA Completed
NCT00399802 2018-08-16
A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT00558272 2013-05-27
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
AstraZeneca
Phase 2 Completed